Healthcare Innovation Hub & Ecosystem

Market Maturity: Exploring

These are innovations that are actively exploring value creation opportunities. Learn more

Market Creation Potential

This innovation was assessed by the JRC’s Market Creation Potential indicator framework as addressing the needs of existing markets and existing customers. Learn more

Women-led innovation

A woman had a leadership role in developing this innovation in at least one of the Key Innovator organisations listed below.

Go to Market needs

Needs that, if addressed, can increase the chances this innovation gets to (or closer to) the market incude:

Prepare for Market entry

Location of Key Innovators developing this innovation

UN Sustainable Development Goals(SDG)

This innovation contributes to the following SDG(s)

SUSTAINABLE DEVELOPMENT GOAL 3

Ensure healthy lives and promote well-being for all at all ages

The UN explains: "Significant strides have been made in increasing life expectancy and reducing some of the common killers responsible for child and maternal mortality.

Major progress has also been made on increasing access to clean water and sanitation, reducing malaria, tuberculosis, polio and the spread of HIV/AIDS.

However, many more efforts are needed to control a wide range of diseases and address many different persistent and emerging health issues."

Discover more innovations related to this SDG

SUSTAINABLE DEVELOPMENT GOAL 9

Build resilient infrastructure, promote inclusive and sustainable industrialization and foster innovation

The UN explains: "Investments in infrastructure – transport, irrigation, energy and information and communication technology – are crucial to achieving sustainable development and empowering communities in many countries. It has long been recognized that growth in productivity and incomes, and improvements in health and education outcomes require investment in infrastructure."

Discover more innovations related to this SDG

The EU-funded Research Project

This innovation was developed under the Horizon 2020 project ALAMEDA with an end date of 31/12/2023

Read more about this project on CORDIS

Description of Project ALAMEDA

Direct costs of brain disorders make up for 60% of the total costs – which EBC estimated at 800 bln€/year in Europe. At European level, this health budget far exceeds that of cardiovascular diseases, brain diseases and diabetes together. ALAMEDA will research, develop and exploit the next generation of personalized AI healthcare support systems that improve the rehabilitation treatment of Parkinson’s, Multiple Sclerosis, and Stroke (PMSS) patients. Stemming from very specific clinical use cases, ALAMEDA will develop user-friendly solutions that will be designed and evaluated on the principles of value-based health. The consortium brings together established medical research teams, AI researchers, medical software vendors and healthcare market experts to demonstrate AI-based personalised prediction, prevention, and intervention approach in three (3) real world pilots. Liaisons have been established with projects MULTI-ACT and IDEA-FAST and the carefully structured workplan, embodies an integrated and harmonized approach with active patients’ engagement towards meeting the ALAMEDA objectives and delivering market-relevant outcomes of significant exploitation potential.

Innnovation Radar's analysis of this innovation is based on data collected on 26/07/2022.
The unique id of this innovation in the European Commission's IT systems is: 109052